ST. PAUL, Minn.--(BUSINESS WIRE)--3M announced today that it has completed its acquisition of Ivera Medical Corp., a manufacturer of health care products that disinfect and protect devices used for access into a patient’s bloodstream. The business is now a wholly owned subsidiary of 3M and a part of its Critical & Chronic Care Solutions Division.
3M’s vascular access products play an important role in helping to reduce complications for patients with I.V. catheters. The addition of Ivera will enable 3M to bring a broader array of vascular access solutions to more health care systems worldwide.
Ivera’s I.V. port connector caps, sold under the Curos® Brand, are used to disinfect and act as a barrier to contamination on devices that provide access to I.V. lines. These products complement 3M’s vascular access products including Tegaderm™ CHG (Chlorhexidine Gluconate) I.V. Securement Dressings, which deliver the critical elements of antimicrobial protection and securement for I.V. site care.
Ivera is based in San Diego, Calif., employs approximately 60 people and has annual sales of approximately $30 million.
About 3M
3M is a science-based company with a culture of
creative collaboration that inspires powerful technologies, making life
better. With $32 billion in sales, 3M employs 90,000 people worldwide
and has operations in more than 70 countries. For more information,
visit www.3M.com
or follow @3MNewsroom on Twitter.
3M, Tegaderm, and Curos are trademarks of 3M.
